Caricamento...
Immunosuppression in inflammatory bowel disease: how much is too much?
PURPOSE OF REVIEW: Current treatment approaches favor the early introduction of immunomodulators and/or antitumor necrosis factor (TNF) agents. There is now strong evidence showing that combination therapy appears to be more effective than monotherapy in both ulcerative colitis and Crohn’s disease....
Salvato in:
| Pubblicato in: | Curr Opin Gastroenterol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681654/ https://ncbi.nlm.nih.gov/pubmed/22573191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0b013e328354567f |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|